Objective: To evaluate the impact of implementation of "report and interpretation of rare pathogenic microorganism isolated" on clinical practice and communication between microbiology laboratory and clinicians. Methods: From Feb 2015, the microbiology laboratory of our hospital added a "report and interpretation of rare pathogenic microorganism isolated" form for the identification report when rare microorganism was isolated from clinical samples,which was considered to be of potential clinical significance. All the "report and interpretation of rare pathogenic microorganism isolated" issued during Feb 2015 to Nov 2016 were analyzed and the information of clinical data of patients and clinician's feedback were collected. SPSS Statistics 19.0 software was used to analyze the data. Results: From Feb 2015 to Nov 2016, 75 "report and interpretation of rare pathogenic microorganism isolated" were sent to 24 clinical departments, which involved 45 kinds of rare microorganism. Susceptibility test could not be performed routinely in Shanghai area on 93.3%(42/45) of the rare pathogens isolated. The average time from sample reception to delivery of the "report and interpretation of rare pathogenic microorganism isolated" was (3.5±1.5) days. After receiving the" report and interpretation of rare pathogenic microorganism isolated", 56.0%(42/75) of clinicians took related actions, with a higher ratio in 2016(62.7%, 37/59) than that in 2015(31.3%, 5/16) (P=0.024). Fifty-nine out of 75 patients from whom rare pathogen was isolated were clinically diagnosed as infectious disease.Patients who accepted therapy according to the recommendation offered with "report and interpretation of rare pathogenic microorganism isolated" had a higher successful rate than those who didn't(P<0.01). Conclusions: The "report and Interpretation of rare pathogenic microorganism isolated" has a positive role in clinical practice, and the clinician's acceptance for the "report and interpretation of rare pathogenic microorganism isolated" is increasing gradually.
LIU Jingxian, CHEN Feng, YU Jing, LIU Ying
. Impact of "Report and Interpretation of Rare Pathogenic Microorganism Isolated" on medical practice[J]. Journal of Diagnostics Concepts & Practice, 2017
, 16(04)
: 399
-403
.
DOI: 10.16150/j.1671-2870.2017.04.011
[1] Loong SK, Khor CS, Jafar FL, et al.Utility of 16S rDNA Sequencing for identification of rare pathogenic bacteria[J]. J Clin Lab Anal,2016,30(6):1056-1060.
[2] Schröttner P, Gunzer F, Schüppel J, et al.Identification of rare bacterial pathogens by 16S rRNA gene sequen-cing and MALDI-TOF MS[J]. J Vis Exp,2016,1(113):e53176.
[3] Arena F, Scolletta S, Marchetti L, et al.Impact of a clinical microbiology-intensive care consulting program in a cardiothoracic intensive care unit[J]. Am J Infect Control,2015,43(9):1018-1021.
[4] Muldoon EG, Allison GM, Gallagher D, et al.Outpatient parenteral antimicrobial therapy (OPAT) in the Republic of Ireland: results of a national survey[J]. Eur J Clin Microbiol Infect Dis,2013,32(11):1465-1470.
[5] 宁永忠. 如何成为感染性疾病临床会诊中的称职检验医师[J]. 中华临床实验室管理电子杂志,2014,2(4):61-64.